SecBot SecBot
144 ·Filed Nov 4, 2026

REGN

REGENERON PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed12d 7h ago SEC0001969223-26-001125
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider sale via option exercise, small relative to market cap. No material signal; monitor for any pattern of larger insider sales in future filings.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$902.90
T+0 close · Nov 4, 2026 · via day close
Latest settled
+5.35%
T+5 · $951.19 · next T+20 in 17d
Vs SPY
+2.06%
α at T+5
Latest observation
+5.21%
T+6 · FF3 residual α
  1. T+0 · Nov 5 $902.90entry
  2. T+1 · 11d ago +0.16%α −0.15% · $904.35
  3. T+5 · 5d ago +5.35%α +2.06% · $951.19
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Jason Pitofsky, an officer of Regeneron Pharmaceuticals, filed a Form 144 notice of intent to sell 3,883 shares of common stock via cashless exercise of stock options granted in 2020, 2021, and 2022. The shares are valued at approximately $3.79 million based on the filing date, representing a small fraction of the company's $99.4 billion market cap.

Key Facts

  • Jason Pitofsky, an officer of Regeneron, filed a Form 144 on November 4, 2026
  • The filing covers 3,883 shares of common stock
  • Shares are to be sold via cashless exercise of stock options granted on 12/09/2020 (905 shares), 12/08/2021 (1,478 shares), and 12/16/2022 (1,500 shares)
  • The approximate market value of the shares is $3,789,808
  • The sale is scheduled for November 4, 2026
  • The shares represent a very small portion of the company's $99.4B market cap (approximately 0.004%)

Financial Impact

Approximately $3.79 million in shares to be sold, representing about 0.004% of market cap

dilution

Risk Factors

  • Form 144 is an intent to sell, not a completed transaction; the sale may not occur
  • Insider selling via option exercise is common and not necessarily a negative signal

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
72% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001969223-26-001125
Document: 0001969223-26-001125-index.html0001969223-26-001125
Document: 0001969223-26-001125.txt0001969223-26-001125

Track record

53 reports on REGN

Performance horizon

11 of 17 bullish or bearish reports moved the stock their way by T+20. Best: +31.76% at T+20 after the Oct 6, 2026 report. 17 of 21 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $951.23 Now $952.40 +0.12% settles Dec 16
  2. Nov 16, 2026today 144 Neutral 2/10 Entry $948.00 Now $952.40 +0.46% settles Dec 16
  3. Nov 12, 20264d ago Press Release Bullish 5/10 Entry $955.47 Now $952.40 −0.32% settles Dec 14
  4. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
  5. Nov 5, 202611d ago Insider Cluster Neutral 3/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
  6. Nov 4, 202612d ago 144 Neutral 1/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
  7. Nov 4, 202612d ago 144 Neutral 2/10 Viewing Entry $902.90 Now $952.40 +5.48% settles Dec 4
  8. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
  9. Nov 3, 202613d ago 144 Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
  10. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
Showing 10 of 53

US Market Status

Market Closed · Opens Wed (9h 42m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026